| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 6.8e-05 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 2.8e-06 | 1 |